was tirzepatide taken off the market Is Zepbound Being Discontinued? Weight Loss Drug Facts Tirzepatide, the active ingredient behind

It acts as a growth hormone (GH) secretagogue stimulating levels of GH and insulin-like growth factor 1 (IGF-1), while preserving GH pulsatility

Tirzepatide is administered subcutaneously once weekly at doses ranging from 2.5 mg to 15 mg, with gradual dose escalation recommended to minimize gastrointestinal adverse effects

If these symptoms are severe or persistent, it is advisable to consult a healthcare professional

Tissue-specific locators are often used, such as portal, periportal, midzonal, centrilobular, hilar, ductal, periductal, peri-canalicular, or subcapsular to indicate the lesion distribution within the liver

R.PickettC